Texas Spine Center
Home Worker's Comp Auto Injury Contact Us Testimonials
Neck and Back Pain Relief at Texas Spine Center

Contact Us for Back Pain Relief
:
First Name
Last Name:
:
Phone
:
Email

Comments:
 

Texas Spine Center
Office: 281-469-0339
Fax:281-469-0369
Toll-Free: 866-469-0339

Office Locations

Northwest Houston
Willowbrook Prof. Bldg. (opposite Methodist Willowbrook Hospital)
13323 Dotson Rd
Suite 100
Houston, TX 77070
» Get Directions

SW/Sugar Land
Memorial Hermann Medical Plaza I
(adjoining Memorial Hermann Hospital)
17510 W Grand Pkwy S Suite 410
Sugar Land, TX 77479
» Get Directions

 

Neck and Back Pain Relief

Vax-D Therapy

Vax-D Treatment in Texas

VAX-D (Vertebral Axial Decompression) is a revolutionary, non-invasive treatment for patients who suffer from chronic low back pain, as well as leg pain and numbness caused from herniated or degenerated discs and posterior facet syndrome. Patients who have had back surgery, yet continue to experience pain, may also be candidates for VAX-D.

Dr. Siddiqi understands that back pain can disrupt the lives of his patients, making it difficult for them to complete simple tasks or enjoy certain activities. While back pain is usually treated with a combination of therapies, including medication, bed-rest, chiropractic care, physical therapy and exercise, many of these treatments only temporarily reduce symptoms.

VAX-D is the only medical device that delivers treatment through its patented logarithmic decompression curve. The treatment is designed to relieve pressure on structures that may be causing back pain usually associated with bulging or herniated discs and degenerative disc disease. VAX-D is safe and effective and does not involve the risks associated with surgery or injections also used to treat chronic back pain.

Dr. Siddiqi performs VAX-D treatments in his offices. If he determines you are a candidate, he will explain all risks and benefits to you before treatment begins.  

How is VAX-D Performed?

Prior to VAX-D treatment, patients are fitted with a patented ‘pelvic harness’ and then are placed in a prone position on a VAX-D table and console (patients remain fully clothed during treatment). The VAX-D Therapeutic Table and Console technology applies and maintains a baseline tension of 20 to 24 pounds to the patient’s pelvis throughout the treatment session (even when at rest). Distraction cycles then move from the 20 to 24 pound range up to a pre-determined tension based on the patients’ condition.

During treatment, patients utilize handgrips to extend the arms above the head (like hanging from a bar) to stabilize and restrain the upper body during lumbar distraction. The pneumatic-hydraulic cylinders of the Table are used to separate the lower table section from the upper section and apply tension to the patient’s pelvis.
 
VAX-D differs from conventional mechanical traction in that it does not treat patients in the face-up position and does not use a chest harness, which tends to restrict breathing and may interrupt blood-flow return to the heart.

Many patients will notice a benefit early on in the treatment protocol, and as treatment progresses, they will experience a gradual reduction of symptoms. 

Length of Treatment

Patients receive an average of 20-25 treatments by a trained technician – one treatment a day for a minimum of five days per week. Each session lasts approximately 45 minutes. The number of treatments needed will vary by patient depending on how severe the condition is and how the patient responds to treatment. Once the initial sessions are complete, patients should continue to receive one session per week for four weeks. Some patients may be able to receive treatments twice a day, but they should be scheduled as far apart as possible.

Patients whose back pain includes inflammation may be prescribed non-steroidal anti-inflammatory agents or other medications. Patients who have tumors, bone fractures or osteoporosis are not candidates for this treatment.

VAX-D clinics have successfully operated for more than ten years in the United States, as well as in Canada, Puerto Rico, Mexico and Australia. More than 3,000 patients each day receive VAX-D therapy in the United States, with studies reporting levels of successful treatment in the range of 70%.

For more information, visit http://www.vax-d.com.